TLDR Women with PCOS often have liver disease, so liver health checks are important for them.
In the 2007 study by Cerda et al., 41% of the 41 women with Polycystic Ovary Syndrome (PCOS) were found to have nonalcoholic fatty liver disease (NAFLD), and 7 of these patients also had elevated aminotransferase levels, indicating a potential progression to nonalcoholic steatohepatitis (NASH). The study highlights the high prevalence of NAFLD among women with PCOS and underscores the importance of evaluating liver health in these patients. Given the association between PCOS and metabolic syndrome—a risk factor for NAFLD—the paper recommends that liver disease assessment should be a standard part of the management for women with PCOS and metabolic syndrome.
270 citations,
April 2007 in “The Journal of Clinical Endocrinology and Metabolism” Women with PCOS often have more belly fat and higher insulin levels, but belly fat isn't the only cause of their insulin resistance.
1744 citations,
August 2006 in “The Journal of Clinical Endocrinology and Metabolism” Polycystic Ovary Syndrome should be seen mainly as a condition of excess male hormones, with a focus on this in its definition.
4809 citations,
January 2004 in “Fertility and Sterility” The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.
378 citations,
September 1998 in “The Journal of Clinical Endocrinology and Metabolism” PCOS affects about 4% of women in the southeastern U.S. equally across Black and White populations.
Early detection and comprehensive treatment of PCOS are crucial due to its long-term health impacts and associated risks.
16 citations,
April 2018 in “Current opinion in gynecology and obstetrics” Hispanic women with PCOS are more likely to have liver diseases like NAFLD and NASH.
114 citations,
March 2018 in “PLOS Medicine” Women with PCOS are more than twice as likely to develop nonalcoholic fatty liver disease.
14 citations,
August 2019 in “BioMed Research International” Belly fat is the main predictor of nonalcoholic fatty liver disease in both women with Polycystic ovary syndrome and healthy women.
45 citations,
January 2013 in “Journal of Human Reproductive Sciences” Women with PCOS are more likely to have fatty liver disease, especially if they have metabolic problems.
August 2015 in “Postgraduate obstetrics & gynecology” Women with PCOS often have metabolic issues like insulin resistance and a higher risk of diabetes and abnormal lipid levels.
